Dr. Wodak is a well-known harm reduction advocate and president of the Australian Drug Law Reform Foundation. He was an early proponent of needle exchange programs and supervised injection facilities for IV drug users.
Calling for an end to arguments over tobacco industry involvement in the e-cig business, and their unproven potential as a gateway to smoking, Wodak argues that three simple questions must define whether e-cigs are beneficial to public health.
“First, do [e-cigs] achieve their objectives – in other words, are they effective? Second, are they safe? Specifically, do they have some serious unintended negative consequences? Third, are they cost effective?”
He goes on to note that the evidence indicates that all three questions can be answered with at least a qualified yes.
As popular opinion in most western countries turns against the “drug war” — the treatment of drug dependence and use as a criminal problem — harm reduction advocates like Dr. Wodak gain influence in the medical and political worlds.
Having that influence applied in favor of e-cigs and low-risk nicotine products can be a huge benefit to the vaping community.
(You can follow Dr. Wodak on Twitter @AlexWodak )